{
     "PMID": "25966970",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20171225",
     "LR": "20180102",
     "IS": "1559-1182 (Electronic) 0893-7648 (Linking)",
     "VI": "53",
     "IP": "5",
     "DP": "2016 Jul",
     "TI": "Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.",
     "PG": "3030-3045",
     "LID": "10.1007/s12035-015-9182-6 [doi]",
     "AB": "Agmatine, an endogenous neuromodulator, is a potential candidate to constitute an adjuvant/monotherapy for the management of depression. A recent study by our group demonstrated that agmatine induces Nrf2 and protects against corticosterone effects in a hippocampal neuronal cell line. The present study is an extension of this previous study by assessing the antidepressant-like effect of agmatine in an animal model of depression induced by corticosterone in mice. Swiss mice were treated simultaneously with agmatine or imipramine at a dose of 0.1 mg/kg/day (p.o.) and corticosterone for 21 days and the daily administrations of experimental drugs were given immediately prior to corticosterone (20 mg/kg/day, p.o.) administrations. Wild-type C57BL/6 mice (Nrf2 (+/+)) and Nrf2 KO (Nrf2 (-/-)) were treated during 21 days with agmatine (0.1 mg/kg/day, p.o.) or vehicle. Twenty-four hours after the last treatments, the behavioral tests and biochemical assays were performed. Agmatine treatment for 21 days was able to abolish the corticosterone-induced depressive-like behavior and the alterations in the immunocontent of mature BDNF and synaptotagmin I, and in the serotonin and glutamate levels. Agmatine also abolished the corticosterone-induced changes in the morphology of astrocytes and microglia in CA1 region of hippocampus. In addition, agmatine treatment in control mice increased noradrenaline, serotonin, and dopamine levels, CREB phosphorylation, mature BDNF and synaptotagmin I immunocontents, and reduced pro-BDNF immunocontent in the hippocampus. Agmatine's ability to produce an antidepressant-like effect was abolished in Nrf2 (-/-) mice. The present results reinforce the participation of Nrf2 in the antidepressant-like effect produced by agmatine and expand literature data concerning its mechanisms of action.",
     "FAU": [
          "Freitas, Andiara E",
          "Egea, Javier",
          "Buendia, Izaskun",
          "Gomez-Rangel, Vanessa",
          "Parada, Esther",
          "Navarro, Elisa",
          "Casas, Ana Isabel",
          "Wojnicz, Aneta",
          "Ortiz, Jose Avendano",
          "Cuadrado, Antonio",
          "Ruiz-Nuno, Ana",
          "Rodrigues, Ana Lucia S",
          "Lopez, Manuela G"
     ],
     "AU": [
          "Freitas AE",
          "Egea J",
          "Buendia I",
          "Gomez-Rangel V",
          "Parada E",
          "Navarro E",
          "Casas AI",
          "Wojnicz A",
          "Ortiz JA",
          "Cuadrado A",
          "Ruiz-Nuno A",
          "Rodrigues ALS",
          "Lopez MG"
     ],
     "AD": "Nina Ireland Laboratory of Developmental Neurobiology, Department of Psychiatry, University of California, San Francisco, San Francisco, CA, 94158, USA. andiaraef@gmail.com. Department of Biochemistry, Center of Biological Sciences, Universidade Federal de Santa Catarina, Campus Universitario, Trindade 88040-900, Florianopolis, Santa Catarina, Brazil. andiaraef@gmail.com. Departamento de Farmacologia y Terapeutica and Instituto Teofilo Hernando. Facultad de Medicina, Universidad Autonoma de Madrid, 28029, Madrid, Spain. andiaraef@gmail.com. Departamento de Farmacologia y Terapeutica and Instituto Teofilo Hernando. Facultad de Medicina, Universidad Autonoma de Madrid, 28029, Madrid, Spain. Instituto de Investigacion Sanitaria Hospital de la Princesa and Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Departamento de Farmacologia y Terapeutica and Instituto Teofilo Hernando. Facultad de Medicina, Universidad Autonoma de Madrid, 28029, Madrid, Spain. Instituto de Investigacion Sanitaria Hospital de la Princesa and Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Departamento de Farmacologia y Terapeutica and Instituto Teofilo Hernando. Facultad de Medicina, Universidad Autonoma de Madrid, 28029, Madrid, Spain. Departamento de Farmacologia y Terapeutica and Instituto Teofilo Hernando. Facultad de Medicina, Universidad Autonoma de Madrid, 28029, Madrid, Spain. Instituto de Investigacion Sanitaria Hospital de la Princesa and Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Departamento de Farmacologia y Terapeutica and Instituto Teofilo Hernando. Facultad de Medicina, Universidad Autonoma de Madrid, 28029, Madrid, Spain. Instituto de Investigacion Sanitaria Hospital de la Princesa and Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Departamento de Farmacologia y Terapeutica and Instituto Teofilo Hernando. Facultad de Medicina, Universidad Autonoma de Madrid, 28029, Madrid, Spain. Department of Pharmacology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands. Instituto de Investigacion Sanitaria Hospital de la Princesa and Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Instituto de Investigacion Sanitaria Hospital de la Princesa and Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Departamento de Bioquimica e Instituto de Investigaciones Biomedicas Alberto Sols UAM-CSIC, Centro de Investigacion en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Instituto de Investigacion Sanitaria Hospital de la Princesa and Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain. Department of Biochemistry, Center of Biological Sciences, Universidade Federal de Santa Catarina, Campus Universitario, Trindade 88040-900, Florianopolis, Santa Catarina, Brazil. Departamento de Farmacologia y Terapeutica and Instituto Teofilo Hernando. Facultad de Medicina, Universidad Autonoma de Madrid, 28029, Madrid, Spain. Instituto de Investigacion Sanitaria Hospital de la Princesa and Servicio de Farmacologia Clinica, Hospital Universitario de la Princesa, Madrid, Spain.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150513",
     "PL": "United States",
     "TA": "Mol Neurobiol",
     "JT": "Molecular neurobiology",
     "JID": "8900963",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Biomarkers)",
          "0 (NF-E2-Related Factor 2)",
          "0 (Neurotransmitter Agents)",
          "70J407ZL5Q (Agmatine)",
          "OGG85SX4E4 (Imipramine)",
          "W980KJ009P (Corticosterone)"
     ],
     "SB": "IM",
     "MH": [
          "Agmatine/*pharmacology",
          "Anhedonia/drug effects",
          "Animals",
          "Antidepressive Agents/pharmacology/therapeutic use",
          "Astrocytes/drug effects/metabolism",
          "*Behavior, Animal",
          "Biomarkers/metabolism",
          "Corticosterone",
          "Depression/drug therapy/*metabolism/pathology/*physiopathology",
          "Female",
          "Hippocampus/drug effects/metabolism/physiopathology",
          "Imipramine/pharmacology/therapeutic use",
          "Mice, Inbred C57BL",
          "Microglia/drug effects/metabolism",
          "Models, Biological",
          "NF-E2-Related Factor 2/*metabolism",
          "Neuronal Plasticity/*drug effects",
          "Neurotransmitter Agents/metabolism",
          "Signal Transduction/drug effects"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*Agmatine",
          "*BDNF",
          "*Corticosterone",
          "*Depression",
          "*Nrf2"
     ],
     "EDAT": "2015/05/15 06:00",
     "MHDA": "2017/12/26 06:00",
     "CRDT": [
          "2015/05/14 06:00"
     ],
     "PHST": [
          "2015/02/04 00:00 [received]",
          "2015/04/15 00:00 [accepted]",
          "2015/05/14 06:00 [entrez]",
          "2015/05/15 06:00 [pubmed]",
          "2017/12/26 06:00 [medline]"
     ],
     "AID": [
          "10.1007/s12035-015-9182-6 [doi]",
          "10.1007/s12035-015-9182-6 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Mol Neurobiol. 2016 Jul;53(5):3030-3045. doi: 10.1007/s12035-015-9182-6. Epub 2015 May 13.",
     "term": "hippocampus"
}